These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1845467)

  • 21. [The relationship of apoB gene polymorphism to dyslipoproteinemia as the cause of atherosclerosis].
    Kravchenko NA
    Tsitol Genet; 1995; 29(4):84-7. PubMed ID: 8604528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dyslipoproteinemia and hyperuricemia in podagra and urinary calculi].
    Barats IS
    Ter Arkh; 1982; 54(10):52-4. PubMed ID: 7179120
    [No Abstract]   [Full Text] [Related]  

  • 23. The genetic basis of primary disorders of intestinal fat transport.
    Levy E
    Clin Invest Med; 1996 Oct; 19(5):317-24. PubMed ID: 8889269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypobetalipoproteinaemia--a variant of the Bassen-Kornzweig syndrome.
    Scott BB; Miller JP; Losowsky MS
    Gut; 1979 Feb; 20(2):163-8. PubMed ID: 428829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phenotype of apolipoprotein E, hyperlipidemia and atherosclerosis].
    Davignon J; Roederer G
    Union Med Can; 1988 Feb; 117(1):56-61. PubMed ID: 3376345
    [No Abstract]   [Full Text] [Related]  

  • 26. Apolipoprotein AIMilano. (The first molecular variant of human apolipoproteins).
    Sirtori CR; Franceschini G
    Ric Clin Lab; 1982; 12(1):83-6. PubMed ID: 6806888
    [No Abstract]   [Full Text] [Related]  

  • 27. [The predictive value of apolipoproteins in atheroma].
    Davignon J
    Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():33-6. PubMed ID: 3113395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Apolipoproteins: valuable indicators of atherogenicity in patients with coronary disease and normal blood lipids].
    Mordasini R; Riesen W
    Ann Med Interne (Paris); 1983; 134(5):479-82. PubMed ID: 6418049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood lipid and apolipoprotein concentrations in a healthy urban population of Northern Cameroon: variation with age and sex].
    Ndomou M; Ngogang J; Kenne M
    Sante; 1999; 9(3):169-72. PubMed ID: 10477406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of serum lipids and apolipoproteins in risk-assessment of coronary heart disease.
    Rifai N; Chapman JF; Silverman LM; Gwynnes JT
    Ann Clin Lab Sci; 1988; 18(6):429-39. PubMed ID: 3071240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardiologic aspects of a case of Tangier disease].
    Plancher AC; Maccari S; Tramaloni C; Vigotti G; Giudici GA
    G Clin Med; 1984; 65(3-4):189-97. PubMed ID: 6234195
    [No Abstract]   [Full Text] [Related]  

  • 35. Apolipoproteins: pathophysiology and clinical implications.
    Patsch W; Gotto AM
    Methods Enzymol; 1996; 263():3-32. PubMed ID: 8748998
    [No Abstract]   [Full Text] [Related]  

  • 36. Classification of inherited hypo- and hyperlipidemia.
    Andersen GE
    Acta Paediatr Scand; 1978 Jul; 67(4):543-7. PubMed ID: 354317
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 4: Apolipoproteinopathia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):129-40. PubMed ID: 1845467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atheroslcerosis. Part I: Principles of classification and methods of dyslipoproteinemia determination.
    Choluj B; Votruba T; Kormúth E
    Acta Univ Carol Med (Praha); 1991; 37(3-4):91-105. PubMed ID: 1845469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 3: Hypertriacylglycerolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):116-28. PubMed ID: 1845466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.